Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (133)

1

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

2

Brief Report : No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Shaffer, D. | Kumwenda, J. | Chen, H. | +12

3

Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Kendall, M. | Lalloo, U. | Fletcher, C. | +5

4

Pharmacokinetic profile and safety of adjusted doses of darunavir/ritonavir with rifampicin in people living with HIV

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Ebrahim, I. | Maartens, G. | Wiesner, L. | +3

5

Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine : a secondary analysis of the ANRS 12174 trial

enthalten in: The lancet. HIV | 2019

von Blanche, S. | Tylleskär, T. | Peries, M. | +9

CommentIn: Lancet HIV. 2019 May;6(5):e272-e273. - PMID 30814029

6

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries : An Observational Analysis Within the EARNEST Randomized Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Thompson, J. | Kityo, C. | Dunn, D. | +10

7

Decreased bone turnover in HIV-infected children on antiretroviral therapy

enthalten in: Archives of osteoporosis | 2018

von Shiau, S. | Yin, M. | Strehlau, R. | +5

8

Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy

enthalten in: AIDS (London, England) | 2018

von Mwasakifwa, G. | Moore, C. | Carey, D. | +10

ErratumIn: AIDS. 2018 Mar 13;32(5):683. - PMID 29494430

9

High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy : A randomized clinical trial

enthalten in: PloS one | 2018

von Pasquau, J. | Hidalgo-Tenorio, C. | Montes, M. | +18

10

Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines

enthalten in: British journal of clinical pharmacology | 2017

von Pressiat, C. | Mea-Assande, V. | Yonaba, C. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]